Giampiero de Luca
Director/Board Member at Auregen Biotherapeutics SA
Profile
Giampiero de Luca is currently a Director at Auregen Biotherapeutics SA, Commave Therapeutics SA, Skylark Bio, Inc., and Stallergenes Canada, Inc. He previously worked as a Director of Intellectual Property at Serono SA from 1988 to 2007 and as a Director at Stallergenes Greer Ltd.
in 2021-2022.
He holds a doctorate degree from the University of Milan.
Giampiero de Luca active positions
Companies | Position | Start |
---|---|---|
Auregen Biotherapeutics SA
Auregen Biotherapeutics SA Packaged SoftwareTechnology Services Auregen Biotherapeutics SA develops three dimensional (3D) bioprinting technology for patients with rare disorders. The company is headquartered in Geneva, Switzerland. | Director/Board Member | - |
Stallergenes Canada, Inc. | Director/Board Member | - |
Skylark Bio, Inc.
Skylark Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Skylark Bio, Inc. operates as a biotechnology company. The company is based in Cambridge, MA. | Director/Board Member | - |
Commave Therapeutics SA
Commave Therapeutics SA Pharmaceuticals: MajorHealth Technology Commave Therapeutics SA is a Swiss pharmaceutical manufacturing company. The private company is based in Geneva, Switzerland. | Director/Board Member | - |
Former positions of Giampiero de Luca
Companies | Position | End |
---|---|---|
STALLERGENES GREER | Director/Board Member | 09/06/2022 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Corporate Officer/Principal | 17/01/2007 |
Training of Giampiero de Luca
University of Milan | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 6 |
---|---|
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
Auregen Biotherapeutics SA
Auregen Biotherapeutics SA Packaged SoftwareTechnology Services Auregen Biotherapeutics SA develops three dimensional (3D) bioprinting technology for patients with rare disorders. The company is headquartered in Geneva, Switzerland. | Technology Services |
Stallergenes Greer Ltd.
Stallergenes Greer Ltd. Pharmaceuticals: MajorHealth Technology Stallergenes Greer Ltd. is a healthcare company, which engages in the development and commercialization of allergy immunotherapy products and services. Its products include sublingual products, subcutaneous products, and veterinary products. The company was founded on December 6, 2013 and headquartered in London, the United Kingdom. | Health Technology |
Stallergenes Canada, Inc. | |
Skylark Bio, Inc.
Skylark Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Skylark Bio, Inc. operates as a biotechnology company. The company is based in Cambridge, MA. | Commercial Services |
Commave Therapeutics SA
Commave Therapeutics SA Pharmaceuticals: MajorHealth Technology Commave Therapeutics SA is a Swiss pharmaceutical manufacturing company. The private company is based in Geneva, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Giampiero de Luca